Compare Edwards Lifesciences Corporation Common Stock (EW) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.22 (market cap $48.56B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $42.06 (market cap $3.80B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 12.8× Vanguard Global ex-US Real Estate Index Fd ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Vanguard Global ex-US Real Estate Index Fd ETF nearer its low. Which is the better fit depends on your goals.
| EW | VNQI | |
|---|---|---|
Market Cap | $48.56B | $3.80B |
Volume | 6,520,488 | 277,049 |
Sector | Health | — |
52-Week High | $95.18 | $50.76 |
52-Week Low | $72.65 | $41.81 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 95 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $41.81, down 0.59% on the day, with a bearish technical signal driven by moving averages. The ETF focuses on international real estate across over 30 countries, offering a higher dividend yield than some peers but lagging in recent total returns. Short interest dropped 45.9% in September (Defense World, 2026-10-02), indicating reduced bearish bets, while the fund's expense ratio remains competitive at 0.12%.
Outlook: VNQI provides diversified global real estate exposure with income appeal, but faces headwinds from international market volatility and currency risks. The bearish technical trend and mixed sentiment suggest caution; long-term investors may value its yield and diversification, though near-term performance depends on global economic conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Vanguard Global ex-US Real Estate Index Fd ETF
The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →
